New transplant method aims to fight disease while reducing dangerous side effects

NCT ID NCT06034535

Recruiting now Disease control Sponsor: Hong Kong Children's Hospital Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Apr 10, 2026 · Updated 24 times

Summary

This study is testing a new way to perform stem cell transplants for people with serious blood cancers or disorders who need a transplant but don't have a perfectly matched donor. Doctors will use specially processed cells from a partially matched family donor, aiming to help the patient's body accept the new cells while reducing the risk of a dangerous complication where the donor cells attack the patient's body. The main goal is to see if patients can survive for one year after the transplant without their body rejecting the new cells or developing this serious complication.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC ORGANS; DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hong Kong Children's Hospital
RECRUITING

Hong Kong, Hong Kong

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HEMATOPOIETIC ORGANS; DISORDER